Dexamethasone is a widely used synthetic glucocorticoid that suppresses the immune system. Long-term treatment with dexamethasone often results in increasesd susceptibility to infections. Among other pathogens, candida albicans is a major threat to immune compromised individuals 1 . Treatment with dexamethasone impairs the maturation of DC in vivo and in vitro. Dexamethasone treated dendritic cells (Dex-DC) show a tolerogenic phenotype which is characterized by lack of co-stimulatory molecules and inhibition of T-cell proliferation 2-4 . In vitro, dexamethasone treatment of DC during their differentiation results in a durable state of immaturity upon stimulation with different ligands 3, 4 .
Defects in the Dectin-1 molecule can result at least in an increased risk for mucosal infections with fungi in affected individuals 21 . In our study we analyzed Dectin-1 expression and signaling in Dex-DC and compared it to immature dendritic cells (iDC).
Results

Dendritic cells generated in the presence of dexamethasone express high levels of Dectin-1, but do not increase expression of maturation markers upon its stimulation. Dectin-1 activation
by beta-glucans mediates anti-fungal immunity and thereby balancing pro-and anti-inflammatory responses upon candida colonization 15, 19, 22 . First, we analyzed whether DC that were generated in the presence of dexamethason (Dex-DC) express Dectin-1 on their surface. We found that Dectin-1 was highly expressed on Dex-DC cells compared to iDC (Fig. 1A,B ). In addition stimulation of iDC with 100 µg/ml zymosan or curdlan increased the expression of the maturation markers CD80, CD83 and CD86. In contrast, Dex-DC show a reduced upregulation of these markers ( Fig. 2A) . PD-L1 expression was found to be increased on both cell subsets after Dectin-1 stimulation with zymosan or curdlan. PD-L2 and HLA-DR were expressed at lower levels on Dex-DC and iDC after stimulation with the indicated beta-glucans. CD11b was expressed at lower levels on Dex-DC as compared to iDC and was downregulated on both cell subsets after stimulation with beta-glucans. CD11b is part of CR3, which was found to be another beta-glucan receptor and collaborating receptor of Dectin-1 23 .
Further characterization of Dex-DC showed that these cells lack CD1a expression and remain CD14 positive as described previously 4 . DC-SIGN, another receptor for C. albicans uptake 24 , was also expressed at lower levels on Dex-DC ( Fig. 2B,C) . Chemokine receptors like CXCR4, CCR7 and FPR2 were expressed on both subsets, presumably enabling both types of antigen-presenting cells to migrate along chemokine gradients to the lymph nodes ( Fig. 2B,C) . The expression of ox40-L was low on both cell types, and was not affected by treatment with dexamethasone and curdlan ( Figure S2 ). In immature dendritic cells generated in the presence of IL-4 and GM-CSF the addition of curdlan resulted in an upregulation of ox40 L on the cell surface.
Dectin-1 stimulated Dex-DC lack allogeneic T-cell stimulatory capacities. Activation of T-cells
requires their interaction with antigen-presenting cells. Apart from interaction of the T-cell-receptor with MHC-I/II molecules (signal one), a second signal (signal two) is required which is facilitated by the interaction with co-stimulatory molecules. A third signal (signal three) is characterized by secretion of cytokines, which polarize T-cells to distinct subsets. Absence of signal two anergizes T-cells.
Dexamethasone-treatment of DC resulted in reduced capacity to stimulate the proliferation of allogeneic T-cells in a mixed lymphocyte reaction (MLR) assay that could not be increased by stimulation with Dectin-1 ligand curdlan or the TLR-4 ligand LPS (Fig. 3A) .
To further analyze the effects of Dex-DC on T cells we assessed the expression of activation markers such as HLA-DR and CD69 on CD4 + T-cells incubated with iDC or Dex-DC. Figure 3B shows the surface expression of both markers on allogeneic CD4 + T-cells incubated with unstimulated or curdlan activated iDC or Dex-DC. Both maturation markers were expressed at lower levels on T-cells incubated with Dex-DCs. Furthermore, these CD4 + allogeneic T-Cells secreted lower levels of IFN-gamma in the presence of Dex-DCs ( Fig. 3C ).
Cytokine secretion of Dex-DC upon stimulation with curdlan.
Next we assessed the cytokine secretion of Dex-DC after stimulation with 100 µg/ml curdlan. Curdlan is a more specific ligand for Dectin-1 that in contrast to zymosan has lower TLR -stimulating properties 25 .
DC generated in the presence of dexamethasone secreted lower amounts of TNF-alpha, IL-23 and IL-12p70 upon stimulation with Curdlan ( Fig. 4 ). Interestingly, secretion of IL-10 was increased in supernatants of Dex-DC. It was previously shown that the secretion of cytokines by DC after stimulation with Dectin-1 is Syk dependent. In line with this we show that an inhibitor of Syk, R406, reduced the production of cytokines by iDC and Dex DC upon incubation of these cells with the Syk-inhibitor R406 (2.5 µM) prior to Dectin-1 stimulation with curdlan ( Fig. 4A ).
In the next set of experiments we analyzed the phoshorylation of Syk in iDC and Dex-DC after stimulation for 30 min with different Dectin-1 ligands ( Fig. 4B ) such as HKCA, Zymosan and Curdlan. Stimulation of Dectin-1 in Dex-DC resulted in increased Syk-phosphorlyation as compared to iDC.
Syk hyperactivation in Dex-DC results in increased generation of superoxide-anions.
Syk-mediated signaling is involved in the generation of ROS in macrophages 18 , DC and neutrophils 26 . Dectin-1 stimulation was previously reported to induce superoxide-anion production 18, 27 . We found that compared to iDC the production of superoxide-anions was highly increased in zymosan or curdlan stimulated Dex-DC ( Fig. 5 ), which was dependent on src, Syk and Dectin-1. Curdlan induced lower amounts of superoxide-anions in Dex-DC and iDC within 45 min of stimulation and higher concentrations of curdlan were required to induce superoxide-anion generation (also see Figure S1 ).
Dectin-1 stimulation results in activation of the MAP-kinases Erk, p38 and STAT3 in
Dex-DC. Downstream of Syk, stimulation of Dectin-1 induces the activation of MAP-Kinases via CARD9 28 . As shown in Fig. 6A stimulation of Dex-DC with beta-glucans resulted in increased phosphorylation of Erk and p38. Interestingly, STAT3 phosphorylation was only detected in Dex-DC upon stimulation with beta-glucans. STAT3 mediates immune inhibitory effects on DC function by promoting expression and secretion of anti-inflammatory cytokines like IL-10 29 and subsequent inhibition of Th1-and Th17-mediated response 29, 30 . Phosphorylation of STAT3, Erk and p38 was decreased in lysates of Dex-DCs when pretreated with the Syk-inhibitor R406 (5 µM) or an anti-Dectin-1 antibody (10 µg/ml) ( Figure S3 ).
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Translocation of the transcription factors NF-κB, NFAT, PU.1, AP.1 and c-Jun is inhibited in Dex-DC upon Dectin-1 stimulation. Next we assessed translocation of transcription factors involved in
Dectin-1 activation and cytokine secretion to the nuclei of iDC and Dex-DC after incubation with beta-glucans ( Fig. 6B ). RelA, c-Rel and RelB, transcription factors of the NF-κB-family, were found at high levels in nuclear extracts of iDC after incubation with curdlan or zymosan whereas extracts of Dex-DC showed only low levels of RelA. Another member of the NF-κB-family, p50, was found to be upregulated in nuclei of iDC and Dex-DC after beta-glucan stimulation. p50 acts as a heterodimer together with p65 do induce transcription. p50-homodimers act as repressors of transcription of pro-inflammatory cytokines 31 , but may induce IL-10 production 32, 33 . 
The phosphatase SHP-1 might contribute to Syk-hyperactivation in Dex-DC. Syk-phosphorylation
is dependent on the activity of membrane-proximal phosphatases. It was shown that the phosphatase CD45 dephosphorylates Syk after completion of Dectin-1-mediated engulfment 34 . We analyzed the expression of CD45 on the surface of iDC and Dex-DC by flow cytometry. We found that CD45 was expressed at similar levels on both cell types (Fig. 6C, left panel) . Next we assessed the expression of SHP-1, which was shown to be involved in regulation of Syk-and STAT3-phosphorylation [35] [36] [37] . In our experiments expression of SHP-1 was reduced in Dex-DC ( Fig. 6C, right panel) , which might contribute to increased Syk-phosphorylation in Dex-DC.
Discussion
Treatment with immunosuppressive agents such as dexamethasone increases the risk of fungal infections. One major threat is the infection with the commensal C. albicans, which can result in mucosal, but also severe systemic infections.
C. albicans is commonly found on healthy individuals where it is kept under control by innate mechanisms as well as Th1-and Th17-cells 38 . Dectin-1 is a non-Toll-like pattern recognition receptor and one of the major receptors for beta-glucans, which represent the main component of the fungal cell wall 5 . Dectin-1 is able to trigger innate and adaptive mechanism of the immune system. In humans, Dectin-1 is widely expressed on DC, macrophages, monocytes, neutrophils, eosinophils, B-cells and distinct T-cell subsets. Dectin-1 is able to induce the secretion of a variety of cytokines and chemokines and can either induce signaling alone or collaborate with Toll-like receptors or other C-type lectins e.g. CR3 23 . Downstream of Dectin-1, signaling is mainly mediated by Syk.
Here we show that dexamethasone treated dendritic cells (Dex-DC) express high levels of Dectin-1 on their surface. In addition, a single stimulation of Dectin-1 with beta-glucans leads to upregulation of Syk phosphorylation at tyrosine residues 525/526 as compared to iDC. Downstream of Syk, we observed a highly increased activation of STAT3 signaling while the induction of STAT3 signaling was absent in iDC. In the nuclei of Dex-DC, we found a reduced expression of NF-κB members RelB, c-Rel and RelA and other transcription factors such as AP-1, c-Jun, NFATC1, STAT1 and PU.1 upon stimulation of Dectin-1 with zymosan or curdlan. NF-κB-family transcription factors are important for differentiation and activation of DC 39 and secretion of cytokines like IL-12 and subsequent Th-1 polarization 40 . The transcription factor PU.1 regulates DC development 41 . NFAT is a transcription factor that is induced by Dectin-1 mediated signaling and promotes cytokine secretion and activation of transcription factors in macrophages and dendritic cells 9 . AP-1 and c-Jun play a role in DC maturation 42 and inflammatory responses 43 . Interestingly, p50 was the only member of the NF-κB family we were able to detect in nuclei of Dex-DC treated with beta-glucans. p50 homodimers are thought to be involved in production of IL-10 32 . These results were in line with STAT3 activation and increased secretion of IL-10. The importance of Syk activation in connection with Dectin-1 mediated IL-10 secretion was already shown by Rogers et al. 11 . They have shown that Syk is essential for Dectin-1mediated IL-10 but not IL-12 secretion in BMDC. The observed increased generation of superoxide-anions in our experiments by Dex-DC upon treatment with beta-glucans might contribute to tissue damage of host cells in mucocutaneous candidiasis [44] [45] [46] . Consequently curdlan treated Dex-DCs had a reduced ability to induce proliferation, IFN-γ secretion or expression of CD69 and HLA-DR by allogeneic T-Cells. Although neutrophils are believed to be the major effector immune cells in defense against systemic fungal infection, we believe that impairment of dendritic cell function affects adaptive immune response, that is believed to be important for control of mucosal fungal infection mainly via Th17 cells which are dependent on cytokines like IL-23 and IL1-beta [47] [48] [49] . Additionally IL-17 produced by Th17 cells is essential for initial recruitment of neutrophils to the site of infection 50 .
The finding, that SHP-1-expression is lower in Dex-DC might contribute to increased Syk phosphorylation and also STAT3 activation. SHP-1 was shown to be a regulator of STAT3 mediated signaling pathways and is currently under investigation as a target for cancer therapy 51 . Another phosphatase, CD45, which is associated with Dectin-1 signaling, was not differentially expressed in iDC and Dex-DC. Furthermore SHP-1 was shown to be sensitive to oxidative inactivation by ROS 52, 53 , which might contribute to further downregulation of phosphatase-activity in Dex-DC.
As already stated Raf-1 is also involved in Dectin-1-mediated signaling. Raf-1 is thought to shape helper cell differentiation by modulation of the NF-κB proteins. Gringhuis et al. 20 described that Raf-1 activation after stimulation of Dectin-1 with curdlan or candida albicans directly influences NF-κB mediated expression of different cytokines. They showed that inhibition or knockout of Raf-1 resulted in abrogated or decreased expression of IL-10, IL-12p35, IL-6 and IL-1beta. On the other hand expression of IL-23 was increased. In our experiments we noticed increased IL-10 production by Dex-DC compared to iDC whereas production of IL-12p70, TNF-alpha and IL-23 was abrogated or decreased. In summary, in our study we identified several mechanisms that promote and support fungal infection upon dexamethasone treatment. Dexamethasone inhibited the function and differentiation of monocyte derived DC and abrogated the immunological effects induced by interaction of fungal beta-glucans with Dectin-1. It inhibited the secretion of cytokines by antigen-presenting cells such as TNF-alpha, IL-12 and IL-23, which are important for T-cell activation and reduced the upregulation of costimulatory molecules on the cell surface upon interaction with beta-glucans. This is probably due to a diminished nuclear expression of several transcription factors involved in DC differentiation and function. Furthermore, dexamethasone increased the expression of Dectin-1 and Syk-phosphorylation but redirected downstream signaling towards STAT-3 that results in production of IL-10, which further contributes to the inhibition of anti-fungal immune responses.
Material and Methods
Ethics Statement. Buffy coats for human monocyte isolation were obtained from voluntary blood donors of the University Hospital Bonn. Approval was obtained from the Institutional Ethics Committee of the University of Bonn, North-Rhine Westphalia, Germany (grant number 173/09).
Written informed consent was obtained for blood donation and further processing of blood samples for scientific purposes by the blood bank/transfusion medicine of the University Hospital of Bonn.
All experiments were performed in accordance with relevant guidelines and regulations.
Media and reagents. Cells were cultured in RPMI 1640 containing glutamax-I, supplemented with 10% inactivated fetal calf serum (RP10 medium) and 1% penicillin/streptomycin (Invitrogen). All reagents not otherwise indicated were purchased from Sigma-Aldrich. HKCA were purchased from InvivoGen (San Diego, CA). Curdlan was purchased from Wako Chemicals USA, Inc. (Richmond, Virginia). Zymosan A was purchased from Sigma-Aldrich.
Detection of superoxide-anion generation. Cells were washed and plated in 24-well cell-culture plate at 5 × 10 5 per well in fresh RP10 medium and were allowed to settle for 2-4 h. Cells were incubated with Inhibitors at the indicated concentrations or an anti-hDectin-1 antibody (R&D Systems, 5 µg/ml) 30 min prior to stimulation with the beta-glucans zymosan (100 µg/ml) or curdlan (100-400 µg/ml). At timepoint of stimulation the superoxide detection reagent (Enzo Life Sciences) was applied to the cells. Cells were stimulated for 45 min, harvested and analyzed by flow cytometry.
Generation of iDCs and Dex-DCs.
Human monocyte-derived DCs (iDCs) were generated from peripheral blood by plastic adherence as described previously 10, 54 . Adherent monocytes were cultured in RP10 medium supplemented with GM-CSF (100 ng/mL; Leukine, Liquid Sargramostim) and IL-4 (20 ng/ml; R&D Systems). Cytokines were added to the cells every other day.
To generate Dex-DC adherent monocytes were treated as described for iDC. Dexamethasone was added furhter at 100 nM every other day. In each case, equal amounts of EtOH were added as a control.
Mixed lymphocyte reaction. 1 × 10 4 of iDCs or Dex-DCs were cultured with a total of 1 × 10 5 responding allogeneic PBMNC as described previously 54 . Tritium-labeled thymidine incorporation was measured on day 5 by a 16-hour pulse with [ 3 H]-thymidine (18.5 kBq/well; GE Healthcare).
Immunostaining for flow cytometry. iDC and Dex-DC were harvested, washed and stained using commercially available mAbs from BD Biosciences, Beckmann Coulter and R&D Systems. Cells were in some cases stimulated for 18 h with zymosan or curdlan (both at 100 µg/ml) prior to flow cytometric analysis. Flow cytometry data was analyzed using FlowJo.
Determination of cytokine production. Concentration of cytokines in cell-culture supernatants was determined using DuoSet ® ELISA Development Systems (R&D systems) according to the manufacturer's instructions. Cells were harvested, washed and seeded in 24-well plates in fresh RP10 media prior to stimulation. Dectin-1 stimulation was accomplished as described for flow cytometric experiments. Inhibitors were added to the cells 30 min prior to stimulation at the indicated concentrations.
Polyacrylamide gel electrophoresis and Western blotting.
Whole cell lysates were prepared as described previously 54 . Protein concentrations were determined using a bicinchoninic acid assay (Pierce, Perbio Science). For analysis of nuclear protein out of 10 6 cells, 20 μl of nuclear extracts were separated on a 10% SDS-PAGE and transferred on a nitrocellulose membrane. Ponceau S staining of the membrane was performed to ensure that equal amounts of protein had been loaded onto the gel. Subsequently, the blot was probed with the indicated antibodies. Protein bands were detected using an enhanced chemiluminescence kit (GE Healthcare).
Statistical analysis.
All experiments were performed at least 3 times, with representative experiments shown. To analyze statistical significance, a Student's t test was used.
